pharmaphorum

OCTOBER 26, 2022

We are working to provide patients, including those living with rare diseases, with safe and effective treatments that improve their quality of life and make these treatments accessible. Every pharma company developing treatments for new diseases is contributing to some degree to better global health.

Development 96

Development Trials Marketing Life Science 96

XTalks

MAY 11, 2023

Moreover, we embed patient centricity far beyond clinical development. Development is just the beginning. Do you think there’s a difference between how large, or more established, pharma companies are trying to incorporate the patient voice versus smaller biotechs?

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease.

Pharma Companies 94

Pharma Companies Marketing Development Insulin 94

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. There’s also that risk of a perceived coercion or influence.

Clinical Trials 101

Clinical Trials Clinical Trials Trials Clinical Research 101

XTalks

OCTOBER 4, 2023

In the specialized, personalized and advanced medicines spaces, this work should start very early — as early as Phase I or Phase II of clinical development. In the specialized, personalized and advanced medicines spaces, this work should start very early — as early as Phase I or Phase II of clinical development.

Marketing 105

Marketing Development Drugs Gene Therapy 105

pharmaphorum

APRIL 7, 2021

With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. He notes that it already has 21 partnerships with pharma companies and will aim to keep more product rights than it did in the past. Role models.

Antibody 91

Antibody Life Science Development Drugs 91

pharmaphorum

NOVEMBER 15, 2022

On 14th November, investors and life science & healthcare executives descended on London’s famed Old Billingsgate building to attend LSX’s Inv€$tival Showcase, part of Europe’s biggest dedicated healthcare investment week. Investing in the future of the European life sciences. For Müllenbeck, this is an opportunity.

Life Science 96

Life Science Pharma Companies Marketing Production 96

XTalks

OCTOBER 22, 2020

However, during the last months, due to COVID-19, we have observed how pharmaceutical companies have progressed very quickly through all the clinical development phases and different companies have already reached the clinical Phase III.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

pharmaphorum

DECEMBER 23, 2020

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. Pharma companies have also made headway in rare diseases as several pipeline projects came to fruition. Rare disease progress.

Marketing 96

Marketing Gene Gene Silencing Drugs 96

XTalks

MARCH 28, 2024

The FDA’s approval of Duvyzat for DMD, based on our robust and successful clinical development program, reflects Italfarmaco’s commitment to providing a safe and proven-effective therapy that can have a meaningful impact for people living with DMD,” said Paolo Bettica, MD, PhD, chief medical officer at Italfarmaco Group in a press release.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

pharmaphorum

MARCH 9, 2021

Last year, Belgium’s ExeVir Bio raised 23 million euros ($27 million) to finance development of llama antibodies – and now it is ready to begin clinical development of a potential treatment that could be effective against emerging COVID-19 variants.

Antibody 98

Antibody Life Science Scientist Development 98

Pharmaceutical Technology

MAY 26, 2023

After raising $125m in 2021 to redevelop the facility, more recently Touchlight secured an additional $17.3m (£14m) from the UK government’s Life Sciences Innovative Manufacturing Fund to accelerate its expansion plans and scale-up equipment.

DNA 130

DNA Manufacturing Gene Gene Therapy 130

Delveinsight

JULY 29, 2020

British-Swedish pharma company AstraZeneca in collaboration with Jenner Institute (Oxford University) is working on Covid-19 vaccine ChAdOx1 nCoV-19 /AZD1222. Based in Ahmedabad, Zydus Cadila is one of the top most pharma companies in the Indian pharmaceutical industry. Zydus Cadila ( ZyCoV-D ).

Vaccine 62

Vaccine Vaccination Clinical Trials Clinical Trials 62

XTalks

JUNE 25, 2024

In the past two years, the industry has faced considerable challenges due to a constrained financing environment, forcing many emerging and early-stage biotech companies to restructure their operations, merge with other companies or narrow their research and development (R&D) efforts by shelving certain assets.

Pharma Companies 52

Pharma Companies Production FDA Approval Vaccine 52

Delveinsight

AUGUST 4, 2021

Similarly, other companies in the domain such as Eisai/ BioArctic AB, Hoffmann-La Roche/Chugai Pharmaceuticals, Anavex Life Sciences Corp., The companies in the Parkinson’s Disease Therapeutics Market include Cortexyme, Cerevel Therapeutics, Amneal Pharmaceuticals, Pharma Two B, Cerevance, AbbVie, Theranexus, and others.

Marketing 98

Marketing Genetics Development Clinical Development 98

pharmaphorum

OCTOBER 10, 2022

Such partnerships are mutually beneficial for all involved parties as pharma companies have a wealth of data, insight, and connections at their disposal, resources that can play a central role in enabling early diagnosis for the NHS and patients. Our ambition is to eliminate cancer as a cause of death.

Development 98

Development Research Marketing Life Science 98

pharmaphorum

APRIL 19, 2021

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. It’s been eventful 12-month period for the UK biotech guru Clive Dix, who has just seen his company C4X Discovery clinch a major inflammatory diseases deal with Sanofi.

Vaccine 98

Vaccine Vaccination Life Science Antibody 98

pharmaphorum

JULY 7, 2022

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients.

Vaccine 52

Vaccine Vaccination Life Science Trials 52

pharmaphorum

DECEMBER 2, 2020

It almost hadn’t made it through clinical development, facing problems with ineffective chiral isomers and limited efficacy in animal testing, but showed such impact in human trials that it blew the competition away. Despite some setbacks, Pfizer remains one of the biggest pharma companies in the world today.

Sales 128

Sales Production Drugs Marketing 128

XTalks

AUGUST 18, 2021

These samples are often made available to support the research efforts of pharma companies developing new antibacterial agents. In addition to drug discovery and development, isolates can also be used in the design and testing of rapid diagnostics tools, and can inform site selection during the clinical trials process.

Development 105

Development Bacteria Drugs Vaccine 105

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

XTalks

MARCH 11, 2025

The Current State of mRNA Analytics There isnt a lot of emphasis right now being put on new method development specifically for application to multivalent mRNA vaccines. And I think this is surprising given just how many multivalent mRNA vaccines are currently in clinical development, begins Dr. Dawson.

Vaccine 64

Vaccine Vaccination Development Manufacturing 64

XTalks

JANUARY 6, 2025

As of January 31, 2024, approximately 131 unique RNA-based therapies are in clinical development across various therapeutic areas. While these therapies span all stages of clinical development, they are particularly concentrated in earlier phases, indicating strong future growth.

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111